Publications
- Rational Design of a New Class of Toll-Like Receptor 4 (TLR4) Tryptamine Related Agonists by Means of the Structure- and Ligand-Based Virtual Screening for Vaccine Adjuvant Discovery2018 | Publication without faculty affiliation
- Rational design of novel TLR4 ligands by in silico screening and their functional and structural characterization in vitro2018 | Publication without faculty affiliation
- Inhibitors of phosphoinositide 3-kinase (PI3K) and phosphoinositide 3-kinase-related protein kinase family (PIKK)2023 | Publication without faculty affiliation
- Strategies for enhanced bioavailability of oxime reactivators in the central nervous system2023 | Publication without faculty affiliation
- BODIPY-labelled acetylcholinesterase reactivators can be encapsulated into ferritin nanovehicles for enhanced bioavailability in the CNS2023 | Publication without faculty affiliation
- Charged pyridinium oximes with thiocarboxamide moiety are equally or less effective reactivators of organophosphate-inhibited cholinesterases compared to analogous carboxamides2022 | Publication without faculty affiliation
- Halogen substituents enhance oxime nucleophilicity for reactivation of cholinesterases inhibited by nerve agents2022 | Publication without faculty affiliation
- Toxicity, pharmacokinetics, and effectiveness of the ortho-chlorinated bispyridinium oxime, K8702022 | Publication without faculty affiliation
- Effects of Novel Tacrine Derivatives on Mitochondrial Energy Metabolism and Monoamine Oxidase Activity-In Vitro Study2021 | First Faculty of Medicine
- Determination of K869, a Novel Oxime Reactivator of Acetylcholinesterase, in Rat Body Fluids and Tissues by Liquid-Chromatography Methods: Pharmacokinetic Study2021 | Faculty of Pharmacy in Hradec Králové
Loading network view...